Figure 3.
Circulating and sc fat SIRT1 changes in T2DM patients.

Circulating and sc fat SIRT1 changes in T2DM patients.

A, Least squares mean change from baseline of circulating SIRT1 in placebo (gray)- and sildenafil (black)-treated patients. Error bars represent upper and lower 95% CI. *, P < .05 between treatment difference. B, Histograms show the relative quantification of SIRT1/GAPDH gene expression in sc AT before and after treatment (baseline, gray; sildenafil, black). Results are expressed as mean ± SD. *, P < .05. C, Least squares mean change from baseline of circulating adiponectin in placebo (gray)- and sildenafil (black)-treated patients. Error bars represent upper and lower 95% CI. *, P < .05 between treatment difference.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close